PMC:7696151 / 111297-111759
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4067 | 71-79 | Species | denotes | patients | Tax:9606 |
| 4068 | 255-263 | Species | denotes | patients | Tax:9606 |
| 4069 | 362-370 | Species | denotes | patients | Tax:9606 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T756 | 0-462 | Sentence | denotes | Gautret et al. (2020) [32] Open-label non-randomized clinical trial36 patients HCQ group -> 600 mg/day HCQ (n = 14); 600 mg/day HCQ +500 mg AZM on day 1 followed by 250 mg/day for 4 days (n = 6)Control group (n = 16)Day 10 On day 6, 70% of HCQ-treated patients were virologically cured comparing to 12.5% in the control groupOn day 6, 100% of HCQ+AZM treated patients are virologically cured comparing to 57.1% in the HCQ group and 12.5% in the control group. |